today announced that it has advanced to a new expansion arm of its Phase 1b/2 clinical trial of Decoy20. This expansion will evaluate the combination of Decoy20 with BeiGene’s PD-1 checkpoint ...

Preliminary Results of Phase 1 Clinical Trial Demonstrate MAX-001 is Well Tolerated with no Serious Adverse Events or Treatment Related Discontinuations MALVERN, Pa., March 18, 2025 /PRNewswire ...

About PD-1 Inhibitors PD-1 inhibitors work by blocking the PD-1 (programmed death-1) receptor on T cells, preventing cancer cells from evading the immune system and restoring the body’s ability to ...

MAX-001 is a Non-Opioid, Non-NSAID Oral Therapy in Development for Treatment of Acute and Chronic Pain Preliminary Results of Phase 1 Clinical Trial Demonstrate MAX-001 is Well Tolerated with no ...

A 2.4-km immersed tunnel, the first of its kind in the Middle East, with 1.25-km underwater at a depth of 30 metres in final stages of completion. • A navigation channel, currently in its final ...

Researchers at the Icahn School of Medicine at Mount Sinai, led by Nina Bhardwaj, MD, Ph.D., Ward-Coleman Chair in Cancer ...

for the Indore Metro Phase 1 project, as reported The Hindustan Times. The contract involves the construction of an 8.65-km-long underground corridor, including tunnels and stations, making it the ...

PD-1 blockade conferred benefit to certain women with surgically resectable endometrial cancer, findings presented at Society ...

Allogene’s phase 1 lymphoma data show CAR-T could ‘leapfrog’ competition: analysts Orca Bio’s open-label phase 3 study enrolled 187 patients with acute myeloid leukemia, acute ...

The trial’s first phase will begin in university hospitals across the Netherlands, Denmark, Germany and Sweden.